Mullertz A - Search Results

1

Oligonucleotide Delivery across the Caco-2 Monolayer: The Design and Evaluation of Self-Emulsifying Drug Delivery Systems (SEDDS).

Kubackova J, Holas O, Zbytovska J, Vranikova B, Zeng G, Pavek P, Mullertz A. Kubackova J, et al. Among authors: mullertz a. Pharmaceutics. 2021 Mar 28;13(4):459. doi: 10.3390/pharmaceutics13040459. Pharmaceutics. 2021. PMID: 33800701 Free PMC article.

2

In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems.

Larsen AT, Sassene P, Müllertz A. Larsen AT, et al. Among authors: mullertz a. Int J Pharm. 2011 Sep 30;417(1-2):245-55. doi: 10.1016/j.ijpharm.2011.03.002. Epub 2011 Mar 15. Int J Pharm. 2011. PMID: 21392564 Review.

3

Lipid-based formulations for oral administration of poorly water-soluble drugs.

Mu H, Holm R, Müllertz A. Mu H, et al. Among authors: mullertz a. Int J Pharm. 2013 Aug 30;453(1):215-24. doi: 10.1016/j.ijpharm.2013.03.054. Epub 2013 Apr 8. Int J Pharm. 2013. PMID: 23578826 Review.

4

Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.

Li P, Tan A, Prestidge CA, Nielsen HM, Müllertz A. Li P, et al. Among authors: mullertz a. Int J Pharm. 2014 Dec 30;477(1-2):390-8. doi: 10.1016/j.ijpharm.2014.10.039. Epub 2014 Oct 17. Int J Pharm. 2014. PMID: 25455781

5

Kolliphor surfactants affect solubilization and bioavailability of fenofibrate. Studies of in vitro digestion and absorption in rats.

Berthelsen R, Holm R, Jacobsen J, Kristensen J, Abrahamsson B, Müllertz A. Berthelsen R, et al. Among authors: mullertz a. Mol Pharm. 2015 Apr 6;12(4):1062-71. doi: 10.1021/mp500545k. Epub 2015 Mar 6. Mol Pharm. 2015. PMID: 25679417

6

Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems.

Mosgaard MD, Sassene P, Mu H, Rades T, Müllertz A. Mosgaard MD, et al. Among authors: mullertz a. Eur J Pharm Biopharm. 2015 Aug;94:493-500. doi: 10.1016/j.ejpb.2015.06.028. Epub 2015 Jul 6. Eur J Pharm Biopharm. 2015. PMID: 26159837

7

Elucidating the Molecular Interactions Occurring during Drug Precipitation of Weak Bases from Lipid-Based Formulations: A Case Study with Cinnarizine and a Long Chain Self-Nanoemulsifying Drug Delivery System.

Sassene PJ, Mosgaard MD, Löbmann K, Mu H, Larsen FH, Rades T, Müllertz A. Sassene PJ, et al. Among authors: mullertz a. Mol Pharm. 2015 Nov 2;12(11):4067-76. doi: 10.1021/acs.molpharmaceut.5b00498. Epub 2015 Sep 30. Mol Pharm. 2015. PMID: 26393273

8

Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine.

Tran T, Xi X, Rades T, Müllertz A. Tran T, et al. Among authors: mullertz a. Int J Pharm. 2016 Apr 11;502(1-2):151-60. doi: 10.1016/j.ijpharm.2016.02.026. Epub 2016 Feb 22. Int J Pharm. 2016. PMID: 26915809

9

Corrigendum to "Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine" [Int. J. Pharm. 502 (1-2) (2016) 151-160].

Tran T, Xi X, Rades T, Müllertz A. Tran T, et al. Among authors: mullertz a. Int J Pharm. 2016 Jun 30;507(1-2):109. doi: 10.1016/j.ijpharm.2016.04.001. Int J Pharm. 2016. PMID: 27241782 No abstract available.

10

Apomorphine and its esters: Differences in Caco-2 cell permeability and chylomicron affinity.

Borkar N, Chen Z, Saaby L, Müllertz A, Håkansson AE, Schönbeck C, Yang M, Holm R, Mu H. Borkar N, et al. Among authors: mullertz a. Int J Pharm. 2016 Jul 25;509(1-2):499-506. doi: 10.1016/j.ijpharm.2016.06.010. Epub 2016 Jun 6. Int J Pharm. 2016. PMID: 27282537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page